BIOMAT Database Logo BIOMAT Database Logo

Utilization of in vivo alkylated metabolites as a possible cause of increased sensitivity to tumor cells to alkylating agents. 1975

M I Lerman, and O Y Abakumova, and N G Kutcenko, and I S Sokolova, and L B Gorbachieva, and A M Serebryannyl

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008770 Methylnitrosourea A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties. Nitrosomethylurea,N-Methyl-N-nitrosourea,NSC-23909,N Methyl N nitrosourea,NSC 23909,NSC23909
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA

Related Publications

M I Lerman, and O Y Abakumova, and N G Kutcenko, and I S Sokolova, and L B Gorbachieva, and A M Serebryannyl
Permeability difference as a source of resistance to alkylating agents in Ehrlich tumor cells.
August 1968, Biochemical and biophysical research communications,
M I Lerman, and O Y Abakumova, and N G Kutcenko, and I S Sokolova, and L B Gorbachieva, and A M Serebryannyl
Use of alkylated proteins in the monitoring of exposure to alkylating agents.
January 1984, IARC scientific publications,
M I Lerman, and O Y Abakumova, and N G Kutcenko, and I S Sokolova, and L B Gorbachieva, and A M Serebryannyl
Formation and metabolism of alkylated nucleosides: possible role in carcinogenesis by nitroso compounds and alkylating agents.
January 1977, Advances in cancer research,
M I Lerman, and O Y Abakumova, and N G Kutcenko, and I S Sokolova, and L B Gorbachieva, and A M Serebryannyl
Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo.
September 1997, The Journal of investigative dermatology,
M I Lerman, and O Y Abakumova, and N G Kutcenko, and I S Sokolova, and L B Gorbachieva, and A M Serebryannyl
[Application of DNA interstrand cross-link assay to estimate the sensitivity of tumor cells to alkylating agents].
November 1990, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
M I Lerman, and O Y Abakumova, and N G Kutcenko, and I S Sokolova, and L B Gorbachieva, and A M Serebryannyl
Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo.
March 1990, Science (New York, N.Y.),
M I Lerman, and O Y Abakumova, and N G Kutcenko, and I S Sokolova, and L B Gorbachieva, and A M Serebryannyl
Differential sensitivity of mouse spermatogenesis to alkylating agents.
March 1961, Genetics,
M I Lerman, and O Y Abakumova, and N G Kutcenko, and I S Sokolova, and L B Gorbachieva, and A M Serebryannyl
Increased sensitivity of chronic lymphocytic leukemia lymphocytes to alkylating agents due to a deficient DNA repair mechanism.
September 1977, European journal of cancer,
M I Lerman, and O Y Abakumova, and N G Kutcenko, and I S Sokolova, and L B Gorbachieva, and A M Serebryannyl
Downregulation of hPMC2 imparts chemotherapeutic sensitivity to alkylating agents in breast cancer cells.
January 2015, Cancer biology & therapy,
M I Lerman, and O Y Abakumova, and N G Kutcenko, and I S Sokolova, and L B Gorbachieva, and A M Serebryannyl
Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.
July 1991, Cancer research,
Copied contents to your clipboard!